Prolyl hydroxylase domain protein 3 targets Pax2 for destruction

Biochemical and Biophysical Research Communications

Volumn 409, Issue 2, 2011, Pages 315-320

  Yan, Bing ^a   Jiao, Shi ^a   Zhang, Hai sheng ^a   Lv, Dan dan ^a   Xue, Jing ^a   Fan, Li ^a   Wu, Guo hao ^b   Fang, Jing ^a  

^a Chinese Academy of Sciences   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cancer; Pax2; PHD3

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; OXYGEN; PROLYL HYDROXYLASE DOMAIN 3 PROTEIN; SYNAPSIN II; TRANSCRIPTION FACTOR PAX2; UNCLASSIFIED DRUG;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DESTRUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DESTRUCTION; PROTEIN EXPRESSION; PROTEIN TARGETING; UPREGULATION;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DIOXYGENASES; HUMANS; PAX2 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 79957894196     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.012     Document Type: Article

References (21)

1. Robson E.J., He S.J., Eccles M.R. A PANorama of PAX genes in cancer and development. Nat. Rev. Cancer 2006, 6:52-62.
2. Lang D., Powell S.K., Plummer R.S., Young K.P., Ruggeri B.A. PAX genes: roles in development, pathophysiology, and cancer. Biochem. Pharmacol. 2007, 73:1-14.
3. Muratovska A., Zhou C., He S., Goodyer P., Eccles M.R. Paired-box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 2003, 22:7989-7997.
4. Luu V.D., Boysen G., Struckmann K., et al. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clin. Cancer Res. 2009, 15:3297-3304.
5. Epstein A.C., Gleadle J.M., McNeill L.A., et al. Elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001, 107:43-54.
6. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340.
7. Luu V.D., Boysen G., Struckmann K., et al. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clin. Cancer Res. 2009, 15:3297-3304.
8. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
9. Schofield C.J., Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 2004, 5:343-354.
10. Ivan M., Kondo K., Yang H., et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001, 292:464-468.
11. Jaakkola P., Mole D.R., Tian Y.M., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
12. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
13. Erez N., Milyavsky M., Eilam R., et al. Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth. Cancer Res. 2003, 63:8777-8783.
14. Kato H., Inoue T., Asanoma K., et al. Induction of human endometrial cancer cell senescence through modulation of HIF-1alpha activity by EGLN1. Int. J. Cancer 2006, 118:1144-1153.
15. Ladroue C., Carcenac R., Leporrier M., et al. PHD2 mutation and congenital erythrocytosis with paraganglioma. N. Engl. J. Med. 2008, 359:2685-2692.
16. Lee S., Nakamura E., Yang H., et al. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 2005, 8:155-167.
17. Koditz J., Nesper J., Wottawa M., et al. Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood 2007, 110:3610-3617.
18. L. Xie, K.H. Xiao, E.J. Whalen et al., Oxygen-regulated beta 2-Adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL, Sci. Signal. 2 (2009) ra33.
19. Fu J., Menzies K., Freeman R.S., et al. EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability. J. Biol. Chem. 2007, 282:12410-12418.
20. Xue J., Li X., Jiao S., et al. Prolyl hydroxylase-3 is downregulated in colorectal cancer cells and inhibits IKKbeta, independent of hydroxylase activity. Gastroenterology 2010, 138:606-615.
21. Masson N., Willam C., Maxwell P.H., et al. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 2001, 20:5197-5206.